SeqOnce Biosciences – Expands Their Pathogen Assay Suite with the Addition of RT-qPCR Measles Panel
CARLSBAD, Calif., July 1, 2025 /PRNewswire/ – SeqOnce, a company focused on the research, development, and commercialization of qPCR and NGS genomics tools for the Infectious Disease Research & CLIA Testing Market, has launched their new Measles Panel A. “This expansion of our best-in-class RT-qPCR assays for our customers ensures that we can effectively partner […]
